Search research articles
Contact Us
Filters
Showing results (461-470 of 514) with videos related to
Page
of 52
Sort By:
Plant Physiology
|
October 11, 2023
PLANT UNCOUPLING MITOCHONDRIAL PROTEIN 2 localizes to the Golgi
Philippe Fuchs, Elisenda Feixes-Prats, Paulo Arruda, et al.
Future Oncology (London, England)
|
January 27, 2022
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol
Najib Ben Khaled, Max Seidensticker, Jens Ricke, et al.
Frontiers in Immunology
|
May 1, 2026
Beyond the interferon score: neurofilament light chain and glial fibrillary acidic protein capture immune-mediated neuroinjury and response to JAK inhibition in Aicardi-Goutières syndrome
Lisa Wege, Christian Klemann, Sandy Siegert, et al.
Journal of Clinical Medicine
|
August 12, 2023
Implementation and Assessment of a Laparotomy-Assisted Three-Port Fetoscopic Spina Bifida Repair Program
Corinna Keil, Siegmund Köhler, Benjamin Sass, et al.
Liver Cancer
|
August 20, 2021
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, et al.
EMBO Molecular Medicine
|
June 25, 2020
Innovations, challenges, and minimal information for standardization of humanized mice
Renata Stripecke, Christian Münz, Jan Jacob Schuringa, et al.
The American Journal of Gastroenterology
|
June 14, 2018
Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related Cirrhosis
Felix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
The American Journal of Gastroenterology
|
March 15, 2018
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis
Felix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
The Lancet. Gastroenterology & Hepatology
|
April 8, 2019
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
Philippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, et al.
Journal of Hepatology
|
March 9, 2016
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study
Michael Bitzer, Marius Horger, Edoardo G Giannini, et al.
Page
of 52
Search research articles
Search
Showing results (461-470 of 514) with videos related to
Sort By:
Page
of 52
Plant Physiology
|
October 11, 2023
PLANT UNCOUPLING MITOCHONDRIAL PROTEIN 2 localizes to the Golgi
Philippe Fuchs, Elisenda Feixes-Prats, Paulo Arruda, et al.
Future Oncology (London, England)
|
January 27, 2022
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol
Najib Ben Khaled, Max Seidensticker, Jens Ricke, et al.
Frontiers in Immunology
|
May 1, 2026
Beyond the interferon score: neurofilament light chain and glial fibrillary acidic protein capture immune-mediated neuroinjury and response to JAK inhibition in Aicardi-Goutières syndrome
Lisa Wege, Christian Klemann, Sandy Siegert, et al.
Journal of Clinical Medicine
|
August 12, 2023
Implementation and Assessment of a Laparotomy-Assisted Three-Port Fetoscopic Spina Bifida Repair Program
Corinna Keil, Siegmund Köhler, Benjamin Sass, et al.
Liver Cancer
|
August 20, 2021
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, et al.
EMBO Molecular Medicine
|
June 25, 2020
Innovations, challenges, and minimal information for standardization of humanized mice
Renata Stripecke, Christian Münz, Jan Jacob Schuringa, et al.
The American Journal of Gastroenterology
|
June 14, 2018
Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related Cirrhosis
Felix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
The American Journal of Gastroenterology
|
March 15, 2018
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis
Felix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
The Lancet. Gastroenterology & Hepatology
|
April 8, 2019
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
Philippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, et al.
Journal of Hepatology
|
March 9, 2016
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study
Michael Bitzer, Marius Horger, Edoardo G Giannini, et al.
Page
of 52